232 related articles for article (PubMed ID: 26202194)
1. Role of Rifaximin in Inflammatory Bowel Disease Treatment.
Scribano ML
Mini Rev Med Chem; 2015; 16(3):225-9. PubMed ID: 26202194
[TBL] [Abstract][Full Text] [Related]
2. Rifaximin in the treatment of inflammatory bowel disease.
Guslandi M
World J Gastroenterol; 2011 Nov; 17(42):4643-6. PubMed ID: 22180705
[TBL] [Abstract][Full Text] [Related]
3. The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease.
Lopetuso LR; Napoli M; Rizzatti G; Gasbarrini A
Expert Opin Investig Drugs; 2018 Jun; 27(6):543-551. PubMed ID: 29865875
[TBL] [Abstract][Full Text] [Related]
4. Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases.
Sartor RB
Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():27-36. PubMed ID: 26618923
[TBL] [Abstract][Full Text] [Related]
5. Role of antibiotics for treatment of inflammatory bowel disease.
Nitzan O; Elias M; Peretz A; Saliba W
World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
[TBL] [Abstract][Full Text] [Related]
6. Management of inflammatory bowel disease: does rifaximin offer any promise?
Gionchetti P; Rizzello F; Morselli C; Romagnoli R; Campieri M
Chemotherapy; 2005; 51 Suppl 1():96-102. PubMed ID: 15855753
[TBL] [Abstract][Full Text] [Related]
7. Review--antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach.
Gionchetti P; Rizzello F; Venturi A; Ugolini F; Rossi M; Brigidi P; Johansson R; Ferrieri A; Poggioli G; Campieri M
Eur Rev Med Pharmacol Sci; 1999; 3(1):27-30. PubMed ID: 10710827
[TBL] [Abstract][Full Text] [Related]
8. Introduction: understanding mechanisms of the actions of rifaximin in selected gastrointestinal diseases.
DuPont HL
Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():1-2. PubMed ID: 26618920
[TBL] [Abstract][Full Text] [Related]
9. Rifaximin: a nonabsorbed oral antibiotic.
Baker DE
Rev Gastroenterol Disord; 2005; 5(1):19-30. PubMed ID: 15741929
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders].
Gasztonyi B; Hunyady B
Orv Hetil; 2004 Oct; 145(43):2177-81. PubMed ID: 15575494
[TBL] [Abstract][Full Text] [Related]
11. Rifaximin and Crohn's disease.
Prantera C; Scribano ML
World J Gastroenterol; 2013 Nov; 19(42):7487-8. PubMed ID: 24259983
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome.
Bruzzese E; Pesce M; Sarnelli G; Guarino A
Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):753-760. PubMed ID: 29897844
[TBL] [Abstract][Full Text] [Related]
13. Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease.
Prantera C; Lochs H; Grimaldi M; Danese S; Scribano ML; Gionchetti P;
Gastroenterology; 2012 Mar; 142(3):473-481.e4. PubMed ID: 22155172
[TBL] [Abstract][Full Text] [Related]
14. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation.
Ponziani FR; Zocco MA; D'Aversa F; Pompili M; Gasbarrini A
World J Gastroenterol; 2017 Jul; 23(25):4491-4499. PubMed ID: 28740337
[TBL] [Abstract][Full Text] [Related]
15. Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome.
Laterza L; Ianiro G; Scoleri I; Landi R; Bruno G; Scaldaferri F; Gaetani E; Campanale M; Gasbarrini A
Expert Opin Pharmacother; 2015 Mar; 16(4):607-15. PubMed ID: 25641072
[TBL] [Abstract][Full Text] [Related]
16. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.
Pimentel M
Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():37-49. PubMed ID: 26618924
[TBL] [Abstract][Full Text] [Related]
17. Use of rifaximin in gastrointestinal and liver diseases.
Shayto RH; Abou Mrad R; Sharara AI
World J Gastroenterol; 2016 Aug; 22(29):6638-51. PubMed ID: 27547007
[TBL] [Abstract][Full Text] [Related]
18. Rifaximin: An Antibiotic with Important Biologic Effects.
DuPont HL
Mini Rev Med Chem; 2015; 16(3):200-5. PubMed ID: 26202192
[TBL] [Abstract][Full Text] [Related]
19. Use of antibiotics in the treatment of inflammatory bowel disease.
Perencevich M; Burakoff R
Inflamm Bowel Dis; 2006 Jul; 12(7):651-64. PubMed ID: 16804403
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobials in the management of inflammatory bowel disease.
Gionchetti P; Rizzello F; Lammers KM; Morselli C; Tambasco R; Campieri M
Digestion; 2006; 73 Suppl 1():77-85. PubMed ID: 16498255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
